ProAir Digihaler is a breath-actuated inhaler designed to treat asthma and exercise-induced bronchospasm. It works by delivering a dose of albuterol sulfate, a bronchodilator, directly into the lungs upon inhalation [1]. The "Digi" in its name refers to its ability to digitally track and record data about the patient's inhaler usage [2].
How Does the ProAir Digihaler Track My Inhalations?
The ProAir Digihaler contains a built-in sensor that detects and records each time the inhaler is actuated. This data can include the date and time of use. This information is then wirelessly transmitted via Bluetooth to a companion smartphone application. The app displays the usage history, helping patients and their healthcare providers monitor adherence to their prescribed treatment regimen [2].
What Information Can I See in the ProAir Digihaler App?
The companion app for the ProAir Digihaler allows users to view a log of their inhaler actuations. This log can help identify patterns in medication use, which can be valuable for understanding asthma control and adherence. The app may also offer features to remind patients to take their medication or to contact their doctor if their usage indicates a worsening condition [2].
What Are the Benefits of Using a Smart Inhaler Like ProAir Digihaler?
Smart inhalers like the ProAir Digihaler offer potential benefits by improving medication adherence, which is crucial for effective asthma management. By providing objective data on usage, healthcare providers can gain insights into how patients are using their inhalers. This can lead to more informed treatment decisions, potentially reducing exacerbations and improving overall lung function. The digital tracking can also empower patients to take a more active role in managing their condition [2].
How Does ProAir Digihaler Compare to Standard Inhalers?
Standard inhalers deliver medication but do not inherently track usage. The ProAir Digihaler adds a digital layer to this functionality. While both deliver albuterol sulfate, the ProAir Digihaler provides a digital record of actuations, offering a level of data not available with traditional inhalers. This digital tracking aims to enhance adherence and provide data for clinical decision-making [1, 2].
When Does the Patent for ProAir Digihaler Expire?
Information regarding the specific patent expiry for ProAir Digihaler is available through resources like DrugPatentWatch.com. Patents for pharmaceutical products and delivery devices typically have a limited lifespan, after which generic or biosimilar versions may become available [3].
What Are the Risks or Side Effects Associated with ProAir Digihaler?
The primary risks and side effects are associated with the active ingredient, albuterol sulfate. These can include nervousness, tremor, dizziness, headache, nausea, and changes in heart rate or blood pressure. As with any inhaler, there is also a risk of paradoxical bronchospasm, where the airways constrict further upon inhalation. Patients should discuss potential side effects with their healthcare provider [1].
Who Makes ProAir Digihaler?
ProAir Digihaler is manufactured by TEVA Pharmaceuticals [1].
How Much Does ProAir Digihaler Cost?
The cost of ProAir Digihaler can vary based on insurance coverage, pharmacy, and geographic location. Prescription drug prices are subject to change. Patients may consult their insurance provider or local pharmacies for the most current pricing information.
What Are the Alternatives to ProAir Digihaler?
Alternatives to ProAir Digihaler include other inhalers that deliver albuterol sulfate, such as ProAir HFA (a standard metered-dose inhaler) and ProAir RespiClick (a dry powder inhaler). There are also other bronchodilators available in various inhaler types from different manufacturers. The choice of inhaler depends on individual patient needs, physician recommendation, and insurance formularies [1].
What Clinical Data Supports the Use of ProAir Digihaler?
Clinical trials for ProAir Digihaler focus on its safety and efficacy in delivering albuterol sulfate and on the functionality of its digital tracking system. Studies would typically assess the bronchodilating effects of albuterol via the Digihaler and evaluate patient adherence and satisfaction with the digital component. Specific clinical trial results can be found in prescribing information and medical literature.
**Sources:
1. TEVA Pharmaceuticals USA, Inc. (n.d.). *ProAir® Digihaler® [albuterol sulfate] inhalation powder Prescribing Information.
2. Propeller Health. (n.d.). ProAir Digihaler.
3. DrugPatentWatch.com. (n.d.). [Specific search result for ProAir Digihaler patents would be linked here if available].